Correlations between GBS patient T cell peptide reactivity and disease severity
| GBS patient subgroup | n | Mean (SE) disability score | p value* | |||
|---|---|---|---|---|---|---|
| *t test. | ||||||
| PMP 22+ | 15 | 3.13 (0.3) | 0.003 | |||
| PMP 22– | 43 | 4.04 (0.14) | ||||
| P0+ | 17 | 3.52 (0.26) | 0.192 | |||
| P0− | 41 | 3.92 (0.16) | ||||
| P2+ | 9 | 3.33 (0.39) | 0.139 | |||
| P2− | 49 | 3.89 (0.14) | ||||
| MBP82–100 or MBP+ | 21 | 3.47 (0.25) | 0.067 | |||
| MBP82–100 or MBP− | 37 | 4.00 (0.16) | ||||
| Any peptide+ | 27 | 3.44 (0.21) | 0.012 | |||
| All peptide − | 31 | 4.12 (0.17) | ||||